0.99Open0.95Pre Close161 Volume1.56K Open Interest80.00Strike Price23.14KTurnover42.64%IV1.03%PremiumDec 13, 2024Expiry Date0.47Intrinsic Value100Multiplier2DDays to Expiry0.83Extrinsic Value100Contract SizeAmericanOptions Type0.5860Delta0.1611Gamma65.69Leverage Ratio-0.3140Theta0.0023Rho38.49Eff Leverage0.0221Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet